FindTrial
Sign In

Comparison of Endoscopic Pilonidal Sinus Treatment with and without Platelet-Rich Plasma in Patients with Pilonidal Sinus

Endoscopic Pilonidal Sinus Treatment (EPSiT) with Platelet-Rich Plasma (PRP) augmentation vs Endoscopic Pilonidal Sinus Treatment (EPSiT) alone for management of pilonidal sinus: A Double-Blind Randomized Controlled Trial - PREST

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111400
Enrollment
62
Registered
2026-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: L059- Pilonidal cyst and sinus without abscess

Interventions

Intervention1: Patients will undergo EPSiT with adjunctive use of PRP injected into the pilonidal sinus tract following the procedure: EPSiT (Endoscopic Pilonidal Sinus Treatment) is used to clean the

Sponsors

All India Institute of Medical Sciences Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient more than 18 years planned for Surgical management of pilonidal sinus

Exclusion criteria

Exclusion criteria: Patients with contraindication to surgery, refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Time to Complete Healing: Defined as the number of days from surgery to the complete healing of the fissure.Timepoint: 30 days—

Secondary

MeasureTime frame
postoperative pain. recovery time, return to work period and quality of life pe 2. To assess cosmetic outcomes such as scar appearance and patient satisfaction in both treatment groups Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Pankaj Kumar

All India Institute of Medical Sciences Bhubaneswar

drpkushwaha@gmail.com9711090814

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026